Reprogramming CD22 CAR-T cells in vivo using CD8-targeted mRNA-LNPs to treat hematological malignancies
Viktor T. Lemgart, Andrew J. Sawyer, William Kuhlman, Aaron P. Griset et autres
10 citationsMolecular Therapy
Ulrik B. Nielsen
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
60Publications signalées
85Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Monoclonal and Polyclonal Antibodies ResearchCancer, Hypoxia, and MetabolismGrowth Hormone and Insulin-like Growth FactorsHER2/EGFR in Cancer ResearchRadiopharmaceutical Chemistry and Applications
Publications récentes
Abstract 6119: Efficient generation of active CAR-T cells from healthy donors and lymphoma patients
Andrew J. Sawyer, Viktor T. Lemgart, William Kuhlman, Aaron P. Griset et autres
2 citationsCancer Research
In Vitro and In Vivo Activity of a Lipid Nanoparticle System for the In Vivo Generation of CAR T Cells
Viktor T. Lemgart, Jennifer Richards, Laura Strauss, Jing Jiao et autres
11 citationsBlood
Born Globals or born nomads? The case of medical cannabis producers in Denmark
0 citationsEdward Elgar Publishing eBooks
Data from Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
Elena Geretti, Shannon C. Leonard, Nancy Dumont, Helen Lee et autres
0 citations
Data from MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
Jonathan B. Fitzgerald, Bryan W. Johnson, Jason Baum, Sharlene Adams et autres
0 citations
Supplementary Tables S1-S3 from Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
Elena Geretti, Shannon C. Leonard, Nancy Dumont, Helen Lee et autres
0 citations
Supplementary Figures S1-S6 from Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
Elena Geretti, Shannon C. Leonard, Nancy Dumont, Helen Lee et autres
0 citations
Supplementary Materials and Methods from Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
Elena Geretti, Shannon C. Leonard, Nancy Dumont, Helen Lee et autres
0 citations
Supplementary Table S1 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
Jeffrey D. Kearns, Raghida A. Bukhalid, Mark Sevecka, Gege Tan et autres
0 citations
Supplementary Tables S5, S6, S7, S8 from Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic
Jeffrey D. Kearns, Raghida A. Bukhalid, Mark Sevecka, Gege Tan et autres
0 citations
Supplementary Tables S1-S3 from Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
Elena Geretti, Shannon C. Leonard, Nancy Dumont, Helen Lee et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.